Follow the Kuros Biosciences AG share price and the full directors' dealings record of the company, a listed issuer based in Switzerland. Shares are quoted on CH CH, under the supervision of SIX SER. Operating in the Health Care sector, Kuros Biosciences AG has logged 9 reports. Market capitalisation: €1.1bn. The latest transaction was disclosed on 16 May 2024 (Purchase). Among the most active insiders: Anonymous (Executive member of the board of directors / member of senior management). The full history is openly available.
9
Insider Decl.
0
Thresholds
€127,769
2 ops.
Buy Volume
€5m
7 ops.
Sell Volume
26Σ signal
Buys €127,769€5m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 14,275 of 26,211 companies
49.4
score / 100
Value
35
Quality
64
FCF yld-0.4%
Earn yld0.3%
EV/EBITDA·
ROE3.3%
Gross mgn89%
Net mgn1.7%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 16 May 2024
Declarations9 total
●
Anonymous (Non-executive member of the board of directors)
Non-executive member of the board of directors·Executives·